Do breast cancer patients tested in the oncology care setting share BRCA mutation results with family members and health care providers?

Journal of Cancer Epidemiology

Volumn , Issue , 2012, Pages

  Vadaparampil, Susan T ^a,b   Malo, Teri ^a   De La Cruz, Cara ^a   Christie, Juliette ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA PROTEIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HEALTH CARE SURVEY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RELATIVE;

EID: 84864949745     PISSN: 16878558     EISSN: 16878566     Source Type: Journal    
DOI: 10.1155/2012/498062     Document Type: Article

References (74)

1. Miki Y., Swensen J., Shattuck-Eidens D., A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 1994 266 5182 66 71 (Pubitemid 24345325)
2. Wooster R., Bignell G., Lancaster J., Swift S., Seal S., Mangion J., Collins N., Gregory S., Gumbs C., Micklem G., Barfoot R., Hamoudl R., Patel S., Rice C., Biggs P., Hashim Y., Smith A., Connor F., Arason A., Gudmundsson J., Ficenec D., Kelsell D., Ford D., Tonin P., Bishop D. T., Spurr N. K., Ponder B. A. J., Eeles R., Peto J., Devilee P., Cornelisse C., Lynch H., Narod S., Lenoir G., Egilsson V., Barkadottir R. B., Easton D. F., Bentley D. R., Futreal P. A., Ashworth A., Stratton M. R., Identification of the breast cancer susceptibility gene BRCA2 Nature 1995 378 6559 789 792 (Pubitemid 26004412)
3. Chen S., Iversen E. S., Friebel T., Characterization of BRCA1 and BRCA2 mutations in a large United States sample Journal of Clinical Oncology 2006 24 6 863 871 (Pubitemid 46638837)
4. Dez O., Cortés J., Domnech M., Pericay C., Brunet J., Alonso C., Baiget M., BRCA2 germ-line mutations in Spanish male breast cancer patients Annals of Oncology 2000 11 1 81 84 (Pubitemid 30084584)
5. Easton D. F., Steele L., Fields P., Ormiston W., Averill D., Daly P. A., McManus R., Neuhausen S. L., Ford D., Wooster R., Cannon-Albright L. A., Stratton M. R., Goldgar D. E., Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13 American Journal of Human Genetics 1997 61 1 120 128 (Pubitemid 27323331)
6. Ford D., Easton D. F., Stratton M., Narod S., Goldgar D., Devilee P., Bishop D. T., Weber B., Lenoir G., Chang-Claude J., Sobol H., Teare M. D., Struewing J., Arason A., Scherneck S., Peto J., Rebbeck T. R., Tonin P., Neuhausen S., Barkardottir R., Eyfjord J., Lynch H., Ponder B. A. J., Gayther S. A., Birch J. M., Lindblom A., Stoppa-Lyonnet D., Bignon Y., Borg A., Hamann U., Haites N., Scott R. J., Maugard C. M., Vasen H., Seitz S., Cannon-Albright L. A., Schofield A., Zelada-Hedman M., Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families American Journal of Human Genetics 1998 62 3 676 689 (Pubitemid 28164626)
7. Liede A., Malik I. A., Aziz Z., De los Rios P., Kwan E., Narod S. A., Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan American Journal of Human Genetics 2002 71 3 595 606 (Pubitemid 34970130)
8. Risch H. A., McLaughlin J. R., Cole D. E. C., Rosen B., Bradley L., Fan I., Tang J., Li S., Zhang S., Shaw P. A., Narod S. A., Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada Journal of the National Cancer Institute 2006 98 23 1694 1706 (Pubitemid 44942707)
9. Tai Y. C., Domchek S., Parmigiani G., Chen S., Breast cancer risk among male BRCA1 and BRCA2 mutation carriers Journal of the National Cancer Institute 2007 99 23 1811 1814 (Pubitemid 351767200)
10. Thompson D., Easton D., Variation in cancer risks, by mutation position, in BRCA2 mutation carriers American Journal of Human Genetics 2001 68 2 410 419 (Pubitemid 32147810)
11. Easton D., Cancer risks in BRCA2 mutation carriers: the breast cancer linkage consortium Journal of the National Cancer Institute 1999 91 15 1310 1316 (Pubitemid 29387573)
12. Eerola H., Pukkala E., Pyrhnen S., Blomqvist C., Sankila R., Nevanlinna H., Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland) Cancer Causes and Control 2001 12 8 739 746 (Pubitemid 32803500)
13. Johannsson O., Loman N., Mller T., Kristoffersson U., Borg., Olsson H., Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers European Journal of Cancer 1999 35 8 1248 1257 (Pubitemid 29359186)
14. Loman N., Bladstrm A., Johannsson O., Borg A., Olsson H., Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status BCR 2003 5 6 R175 R186
15. Bermejo J. L., Hemminki K., Risk of cancer at sites other than the breast in Swedish families eligible for BRCA1 or BRCA2 mutation testing Annals of Oncology 2004 15 12 1834 1841 (Pubitemid 40012250)
16. Moslehi R., Chu W., Karlan B., Fishman D., Risch H., Fields A., Smotkin D., Ben-David Y., Rosenblatt J., Russo D., Schwartz P., Tung N., Warner E., Rosen B., Friedman J., Brunet J. S., Narod S. A., BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer American Journal of Human Genetics 2000 66 4 1259 1272 (Pubitemid 30468783)
17. Thorlacius S., Sigurdsson S., Bjarnadottir H., Olafsdottir G., Jonasson J. G., Tryggvadottir L., Tulinius H., Eyfjrd J. E., Study of a single BRCA2 mutation with high carrier frequency in a small population American Journal of Human Genetics 1997 60 5 1079 1084 (Pubitemid 27194092)
18. Tulinius H., Eyfjord J. E., Olafsdottir G. H., Sigvaldason H., Arason A., Barkardottir R. B., Egilsson V., Ogmundsdottir H. M., Tryggvadottir L., Gudlaugsdottir S., The effect of a single BRCA2 mutation on cancer in Iceland Journal of Medical Genetics 2002 39 7 457 462 (Pubitemid 34787737)
19. Van Asperen C. J., Brohet R. M., Meijers-Heijboer E. J., Hoogerbrugqe N., Verhoef S., Vasen H. F. A., Ausems M. G. E. M., Menko F. H., Gomez Garcia E. B., Klijn J. G. M., Hogervorst F. B. L., Van Houwelingen J. C., Van't Veer L. J., Rookus M. A., Van Leeuwen F. E., Cancer risks in BRCA2 families: estimates for sites other than breast and ovary Journal of Medical Genetics 2005 42 9 711 719 (Pubitemid 41306062)
20. Warner E., Foulkes W., Goodwin P., Meschino W., Blondal J., Paterson C., Ozcelik H., Goss P., Allingham-Hawkins D., Hamel N., Di Prospero L., Contiga V., Serruya C., Klein M., Moslehi R., Honeyford J., Liede A., Glendon G., Brunet J. S., Narod S., Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer Journal of the National Cancer Institute 1999 91 14 1241 1247 (Pubitemid 29357191)
21. Edwards S. M., Kote-Jarai Z., Meitz J., Hamoudi R., Hope Q., Osin P., Jackson R., Southgate C., Singh R., Falconer A., Dearnaley D. P., Ardern-Jones A., Murkin A., Dowe A., Kelly J., Williams S., Oram R., Stevens M., Teare D. M., Ponder B. A. J., Gayther S. A., Easton D. F., Eeles R. A., Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene American Journal of Human Genetics 2003 72 1 1 12 (Pubitemid 36056838)
22. Gayther S. A., De Foy K. A. F., Harrington P., Pharoah P., Dunsmuir W. D., Edwards S. M., Gillett C., Ardern-Jones A., Dearnaley D. P., Easton D. F., Ford D., Shearer R. J., Kirby R. S., Dowe A. L., Kelly J., Stratton M. R., Ponder B. A. J., Barnes D., Eeles R. A., The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer Cancer Research 2000 60 16 4513 4518 (Pubitemid 32103633)
23. Giusti R. M., Rutter J. L., Duray P. H., Freedman L. S., Konichezky M., Fisher-Fischbein J., Greene M. H., Maslansky B., Fischbein A., Gruber S. B., Rennert G., Ronchetti R. D., Hewitt S. M., Struewing J. P., Iscovich J., A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology Journal of Medical Genetics 2003 40 10 787 792 (Pubitemid 37311080)
24. Kirchhoff T., Kauff N. D., Mitra N., Nafa K., Huang H., Palmer C., Gulati T., Wadsworth E., Donat S., Robson M. E., Ellis N. A., Offit K., BRCA2 mutation in Icelandic prostate cancer patients Clinical Cancer Research 2004 10 9 2918 2921
25. Sigurdsson S., Thorlacius S., Tomasson J., Tryggvadottir L., Benediktsdottir K., Eyfjrd J. E., Jonsson E., BRCA2 mutation in Icelandic prostate cancer patients Journal of Molecular Medicine 1997 75 10 758 761 (Pubitemid 27451978)
26. Willems A. J., Dawson S. J., Samaratunga H., De Luca A., Antill Y. C., Hopper J. L., Thorne H. J., Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation Clinical Cancer Research 2008 14 10 2953 2961
27. Agalliu I., Karlins E., Kwon E. M., Iwasaki L. M., Diamond A., Ostrander E. A., Stanford J. L., Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer British Journal of Cancer 2007 97 6 826 831 (Pubitemid 47396283)
28. Barsevick A. M., Montgomery S. V., Ruth K., Ross E. A., Egleston B. L., Bingler R., Malick J., Miller S. M., Cescon T. P., Daly M. B., Intention to communicate BRCA1 / BRCA2 genetic test results to the family Journal of Family Psychology 2008 22 2 303 312
29. Domchek S. M., Friebel T. M., Singer C. F., Gareth Evans D., Lynch H. T., Isaacs C., Garber J. E., Neuhausen S. L., Matloff E., Eeles R., Pichert G., Van T'veer L., Tung N., Weitzel J. N., Couch F. J., Rubinstein W. S., Ganz P. A., Daly M. B., Olopade O. I., Tomlinson G., Schildkraut J., Blum J. L., Rebbeck T. R., Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality JAMA 2010 304 9 967 975
30. King M. C., Wieand S., Hale K., Lee M., Walsh T., Owens K., Tait J., Ford L., Dunn B. K., Costantino J., Wickerham L., Wolmark N., Fisher B., Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2 national surgical adjuvant breast and bowel project (nsabp-p1) breast cancer prevention trial JAMA 2001 286 18 2251 2256 (Pubitemid 33063147)
31. Narod S. A., Brunet J. S., Ghadirian P., Robson M., Heimdal K., Neuhausen S. L., Stoppa-Lyonnet D., Lerman C., Pasini B., De Los Rios P., Weber B., Lynch H., Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study The Lancet 2000 356 9245 1876 1881
32. Daly M.,. The NCCN Genetic/Familial High-Risk Assessment: Breast and Ovarian Clinical Practice Guideline, version 1, 2009, http://www.nccn.org/ professionals/physiciangls/PDF/geneticsscreening.pdf
33. Sifri R., Gangadharappa S., Acheson L. S., Identifying and testing for hereditary susceptibility to common cancers CA: A Cancer Journal for Clinicians 2004 54 6 309 326 (Pubitemid 40073989)
34. Vos J., Jansen A. M., Menko F., Van Asperen C. J., Stiggelbout A. M., Tibben A., Family communication matters: the impact of telling relatives about unclassified variants and uninformative DNA-test results Genetics in Medicine 2011 13 4 333 341
35. Bruinooge S. S., American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility Journal of Clinical Oncology 2003 21 12 2397 2406 (Pubitemid 46908372)
36. ASHG Statement, Professional disclosure of familial genetic information. The American Society of Human Genetics Social Issues Subcommittee on Familial Disclosure American Journal of Human Genetics 1998 62 2 474 483
37. Bradbury A. R., Dignam J. J., Ibe C. N., Auh S. L., Hlubocky F. J., Cummings S. A., White M., Olopade O. I., Daugherty C. K., How often do BRCA mutation carriers tell their young children of the family's risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adults Journal of Clinical Oncology 2007 25 24 3705 3711 (Pubitemid 47372611)
38. Bradbury A. R., Patrick-Miller L., Egleston B. L., Olopade O. I., Daly M. B., Moore C. W., Sands C. B., Schmidheiser H., Kondamudi P. K., Feigon M., Ibe C. N., Daugherty C. K., When parents disclose BRCA1/2 test results: their communication and perceptions of offspring response Cancer 2012 118 13 3417 3425
39. Cheung E. L., Olson A. D., Yu T. M., Han P. Z., Beattie M. S., Communication of BRCA results and family testing in 1,103 high-risk women Cancer Epidemiology Biomarkers and Prevention 2010 19 9 2211 2219
40. Claes E., Evers-Kiebooms G., Boogaerts A., Decruyenaere M., Denayer L., Legius E., Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients American Journal of Medical Genetics 2003 116 1 11 19 (Pubitemid 36008062)
41. Finlay E., Stopfer J. E., Burlingame E., Evans K. G., Nathanson K. L., Weber B. L., Armstrong K., Rebbeck T. R., Domchek S. M., Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations Genetic Testing 2008 12 1 81 91 (Pubitemid 351457781)
42. Hughes C., Lerman C., Schwartz M., Peshkin B. N., Wenzel L., Narod S., Corio C., Tercyak K. P., Hanna D., Isaacs C., Main D., All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results American Journal of Medical Genetics 2002 107 2 143 150 (Pubitemid 34038596)
43. Patenaude A. F., Dorval M., DiGianni L. S., Schneider K. A., Chittenden A., Garber J. E., Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell Journal of Clinical Oncology 2006 24 4 700 706 (Pubitemid 46630437)
44. Gadzicki D., Wingen L. U., Teige B., Horn D., Bosse K., Kreuz F., Goecke T., Schfer D., Voigtlnder T., Fischer B., Froster U., Welling B., Debatin I., Weber B. H. F., Schnbuchner I., Nippert I., Schlegelberger B., Communicating BRCA1 and BRCA2 genetic test results Journal of Clinical Oncology 2006 24 18 2969 2970 (Pubitemid 46630607)
45. MacDonald D. J., Sarna L., Van Servellen G., Bastani R., Giger J. N., Weitzel J. N., Selection of family members for communication of cancer risk and barriers to this communication before and after genetic cancer risk assessment Genetics in Medicine 2007 9 5 275 282 (Pubitemid 46788193)
46. McGivern B., Everett J., Yager G. G., Baumiller R. C., Hafertepen A., Saal H. M., Family communication about positive BRCA1 and BRCA2 genetic test results Genetics in Medicine 2004 6 6 503 509 (Pubitemid 39576543)
47. Segal J., Esplen M. J., Toner B., Baedorf S., Narod S., Butler K., An investigation of the disclosure process and support needs of BRCA1 and BRCA2 carriers American Journal of Medical Genetics 2004 125 3 267 272 (Pubitemid 38294845)
48. Costalas J. W., Itzen M., Malick J., Babb J. S., Bove B., Godwin A. K., Daly M. B., Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience American Journal of Medical Genetics 2003 119 1 11 18 (Pubitemid 37064096)
49. Dancyger C., Wiseman M., Jacobs C., Smith J. A., Wallace M., Michie S., Communicating BRCA1/2 genetic test results within the family: a qualitative analysis Psychology and Health 2011 26 8 1018 1035
50. Morgan D., Sylvester H., Lee Lucas F., Miesfeldt S., Hereditary breast and ovarian cancer: referral source for genetic assessment and communication regarding assessment with nongenetic clinicians in the community setting Genetics in Medicine 2010 12 1 25 31
51. Ready K., Arun B. K., Schmeler K. M., Uyei A., Litton J. K., Lu K. H., Sun C. C., Peterson S. K., Communication of BRCA1 and BRCA2 genetic test results to health care providers following genetic testing at a tertiary care center Familial Cancer 2011 10 4 1 7
52. Hamann H. A., Somers T. J., Smith A. W., Inslicht S. S., Baum A., Posttraumatic stress associated with cancer history and BRCA1/2 genetic testing Psychosomatic Medicine 2005 67 5 766 772 (Pubitemid 41396024)
53. Lerman C., Croyle R. T., Tercyak K. P., Hamann H., Genetic testing: psychological aspects and implications Journal of Consulting and Clinical Psychology 2002 70 3 784 797 (Pubitemid 34640743)
54. Meiser B., Psychological impact of genetic testing for cancer susceptibility: an update of the literature Psycho-Oncology 2005 14 12 1060 1074 (Pubitemid 43019695)
55. Julian-Reynier C., Eisinger F., Chabal F., Lasset C., Nogus C., Stoppa-Lyonnet D., Vennin P., Sobol H., Disclosure to the family of breast/ovarian cancer genetic test results: patient's willingness and associated factors American Journal of Medical Genetics 2000 94 1 13 18 (Pubitemid 30629350)
56. Valverde K. D., Why me? Why not me? Journal of Genetic Counseling 2006 15 6 461 463 (Pubitemid 44900662)
57. Wagner T. M. U., Mslinger R., Langbauer G., Ahner R., Fleischmann E., Auterith A., Friedmann A., Helbich T., Zielinski C., Pittermann E., Seifert M., Oefner P., Concin H., Doeller W., Haid A., Lang A. H., Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations British Journal of Cancer 2000 82 7 1249 1253 (Pubitemid 30145340)
58. Cypowyj C., Eisinger F., Huiart L., Sobol H., Morin M., Julian-Reynier C., Subjective interpretation of inconclusive BRCA1/2 cancer genetic test results and transmission of information to the relatives Psycho-Oncology 2009 18 2 209 215
59. Hallowell N., Foster C., Ardern-Jones A., Eeles R., Murday V., Watson M., Genetic testing for women previously diagnosed with breast/ovarian cancer: examining the impact of BRCA1 and BRCA2 mutation searching Genetic Testing 2002 6 2 79 87
60. Mohamad H. B., Apffelstaedt J. P., Counseling for male BRCA mutation carriersa review Breast 2008 17 5 441 450
61. Daly M. B., Axilbund J. E., Buys S., Crawford B., Farrell C. D., Friedman S., Garber J. E., Goorha S., Gruber S. B., Hampel H., Kaklamani V., Kohlmann W., Kurian A., Litton J., Marcom P. K., Nussbaum R., Offit K., Pal T., Pasche B., Pilarski R., Reiser G., Shannon K. M., Smith J. R., Swisher E., Weitzel J. N., Genetic/familial high-risk assessment: breast and ovarianclinical practice guidelines in oncology JNCCN 2010 8 5 562 594
62. Borry P., Stultiens L., Nys H., Cassiman J. J., Dierickx K., Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers Clinical Genetics 2006 70 5 374 381 (Pubitemid 44515636)
63. Bradbury A. R., Patrick-Miller L., Pawlowski K., Ibe C. N., Cummings S. A., Hlubocky F., Olopade O. I., Daugherty C. K., Learning of your parent's BRCA mutation during adolescence or early adulthood: a study of offspring experiences Psycho-Oncology 2009 18 2 200 208
64. Peshkin B. N., Demarco T. A., Tercyak K. P., On the development of a decision support intervention for mothers undergoing BRCA1/2 cancer genetic testing regarding communicating test results to their children Familial Cancer 2010 9 1 89 97
65. Tercyak K. P., Peshkin B. N., DeMarco T. A., Brogan B. M., Lerman C., Parent-child factors and their effect on communicating BRCA1/2 test results to children Patient Education and Counseling 2002 47 2 145 153 (Pubitemid 34626402)
66. Levy D. E., Byfield S. D., Comstock C. B., Garber J. E., Syngal S., Crown W. H., Shields A. E., Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk Genetics in Medicine 2011 13 4 349 355
67. Vadaparampil S. T., Quinn G. P., Miree C. A., Brzosowicz J., Carter B., Laronga C., Recall of and reactions to a surgeon referral letter for BRCA genetic counseling among high-risk breast cancer patients Annals of Surgical Oncology 2009 16 7 1973 1981
68. Keating N. L., Stoeckert K. A., Regan M. M., DiGianni L., Garber J. E., Physicians' experiences with BRCA1/2 testing in community settings Journal of Clinical Oncology 2008 26 35 5789 5796
69. Wideroff L., Freedman A. N., Olson L., Klabunde C. N., Davis W., Srinath K. P., Croyle R. T., Ballard-Barbash R., Physician use of genetic testing for cancer susceptibility: results of a national survey Cancer Epidemiology Biomarkers and Prevention 2003 12 4 295 303 (Pubitemid 36427989)
70. Wideroff L., Vadaparampil S. T., Greene M. H., Taplin S., Olson L., Freedman A. N., Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians Journal of Medical Genetics 2005 42 10 749 755 (Pubitemid 41475249)
71. Patterson A. R., Robinson L. D., Naftalis E. Z., Haley B. B., Tomlinson G. E., Custodianship of genetic information: clinical challenges and professional responsibility Journal of Clinical Oncology 2005 23 9 2100 2104 (Pubitemid 46211389)
72. Snyder C. F., Frick K. D., Peairs K. S., Kantsiper M. E., Herbert R. J., Blackford A. L., Wolff A. C., Earle C. C., Comparing care for breast cancer survivors to non-cancer controls: a five-year longitudinal study Journal of General Internal Medicine 2009 24 4 469 474
73. Offit K., Groeger E., Turner S., Wadsworth E. A., Weiser M. A., The duty to warn a patient's family members about hereditary disease risks JAMA 2004 292 12 1469 1473 (Pubitemid 39258340)
74. Lehmann L. S., Weeks J. C., Klar N., Biener L., Garber J. E., Disclosure of familial genetic information: perceptions of the duty to inform American Journal of Medicine 2000 109 9 705 711 (Pubitemid 32013018)